SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-027676
Filing Date
2023-10-04
Accepted
2023-10-04 17:03:42
Documents
3
Period of Report
2023-11-13

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A rvph20230927_def14a.htm DEF 14A 383905
2 proxycard_page1.jpg GRAPHIC 112875
3 proxycard_page2.jpg GRAPHIC 104599
  Complete submission text file 0001437749-23-027676.txt   684637
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38634 | Film No.: 231308776
SIC: 2834 Pharmaceutical Preparations